Back to Top

"One of today's leaders in investor relations and shareholder services"

Tag Archives: CBD

AXIM IBS Treatment Options and Market Growth in 2017 and Beyond

AXIM

Irritable bowel syndrome is a chronic condition characterized by discomfort and pain in the abdominal region. Sufferers also experience symptoms such as diarrhea, constipation and gas, and it is believed that the condition is adversely affected by anxiety. Anywhere between 25 and 45 million people are affected by IBS in the United States alone, and 2 out of 3 IBS patients are women. The unfortunate reality for IBS sufferers is that there are few effective long-term treatments that manage symptoms without the risk of side effects. As a result, the IBS market presents plenty of opportunities for alternative treatment methods to make a positive impact on patients worldwide.

Medical Marijuana Products

Pharmaceutical industry experts predict that the market for cannabis products could reach 10 percent of the specialty market by the year 2020, with a market value of $20 billion. With a variety of cannabinoids to test and incorporate …

Continue Reading

Posted in Articles| Tagged , , , , |

ChineseInvestors.com, Inc. (CIIX) Aiming to Help Tackle Epilepsy with a CBD Oil-Based Pharmaceutical

ChineseInvestors.com, Inc. (OTCQB: CIIX), a company in the business of providing Chinese-speaking investors with real-time market analysis, commentary, and educational services, recently announced its goals for 2017, stating that it plans to develop a CBD oil-based pharmaceutical that could help with the major problem of epilepsy in China.

CBD, also known as cannabidiol, is one of the most important healing substances in the hemp plant, helping treat inflammation, convulsions, insomnia, anxiety, ulcers, neuropathic pain, and epilepsy, among other medical problems. The difference between CBD and THC is that THC is classified as a federally controlled psychotropic drug, whereas CBD is recognized as…

Read more ยป

About NetworkNewsWire

NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of journalists and writers, NNW is uniquely positioned to best serve private …

Continue Reading

Posted in Client News| Tagged , |

ChineseInvestors.com (OTCQB: CIIX), Announces the Launch of its New Website for its New Subsidiary ChineseCBDoil.com

NEW YORK, February 1, 2017 /PRNewswire/ — ChineseInvestors.com (OTCQB: CIIX), is pleased to announce the launch of its new website for its new subsidiary ChineseCBDoil.com. The website went live on January 31st under the URL: http://www.ChineseCBDoil.com. The Company is expanding into the medical marijuana industry with the launch of its website and plans to retail hemp oil and related products, which are legal to sell and distribute within China and in the United States in all fifty states (hemp oil is not marijuana, but indeed a separate and distinct plant made from hemp). CBD oil, derived from hemp is a product with medicinal qualities that are primarily used for anti-inflammatory and other common ailments. Its website is intended for the Chinese speaking population, a global market of 2 Billion people.

Mr. Warren Wang, the Chairman of ChineseInvestors.com stated: “I am very pleased to see the investor reaction to our announced …

Continue Reading

Posted in Client News| Tagged , , |

1-30-17 SmallCapVoice Interview with Chineseinvestors.com, Inc. (CIIX)

Chineseinvestors.com, Inc. (CIIX)

Alan Klitenic, director of Investor Relations for ChineseInvestors.com (OTCQB: CIIX) (the “Company”), called in to SmallCapVoice.com, Inc. to go over the business model, markets, milestones and 2017 outlook for the Company. Founded in 1999, ChineseInvestors.com, Inc. endeavors to be an innovative company providing (a) real-time market commentary, analysis, and educational related services in Chinese language character sets (traditional and simplified); (b) support services to various partners; (c) consultative services to smaller private companies considering becoming a public company; (d) advertising and public relation related support services; and (e) other services we may identify having the potential to create value or partnership opportunity with our existing services. Recently, the Company announced a new wholesale agreement that enables CIIX to retail nutritional supplements containing CBD to the Asian market through both online and in-store sales. The CBD company’s flagship product is the top-selling brand of hemp-derived CBD oil for consumers in …

Continue Reading

Posted in Interviews| Tagged , , |

ChineseInvestors.com, Inc. (CIIX) Engages NetworkNewsWire for Corporate Communications Solutions

NEW YORK, NY–(Marketwired – Jan 25, 2017) – ChineseInvestors.com, Inc. (the “Company”) (OTCQB: CIIX), the premier financial information website for Chinese-speaking investors in both the U.S. and China, announces that it has engaged the expertise of NetworkNewsWire (“NNW”), a multifaceted financial news and publishing company that delivers a new generation of social communication solutions, news aggregation and syndication, and enhanced news release services. NNW’s solutions help public and private organizations find their voice and build market visibility via social media and a rapidly expanding distribution network of well over 5,000 key syndication outlets.

“ChineseInvestors.com has a strong history of providing investment-based education products and services. We are now taking significant strides to expand our operations and capitalize on the lucrative growth of the cannabis industry with the upcoming and previously announced launch of www.ChineseCBDoil.com,” says Warren Wang, founder and CEO of CIIX. “This is an opportunity we certainly do not …

Continue Reading

Posted in Client News| Tagged , , |

MJTV Engages Dr. Gregory Smith As Chief Medical Advisor

WHIPPANY, NJ–(Marketwired – Jan 25, 2017) – Michael James Enterprises, Inc. (OTCQB: MJTV) is extremely pleased to bring on Gregory Smith, M.D. as Chief Medical Advisor to consult with MJTV on the Voluptas Project as well the different Neuroceuticals the Company has under development.

Dr. Smith earned his medical degree from Rush Medical School in Chicago as well as his Master of Public Health from Harvard University. He completed residency training in Preventive Medicine at Walter Reed Army Medical Center. Since leaving the US Army with the rank of Major, Doctor Smith has been in primary Practice care in California, Georgia and Florida for the past 25 plus years.

Doctor Smith trained on the use of cannabinoid pharmaceuticals in California in 2000, and has consulted with several biosynthetic cannabinoid manufacturers over past four years. Dr. Smith wrote “Medical Cannabis: Basic Science and Clinical Applications,” in 2016 published by Aylesbury Press. …

Continue Reading

Posted in Client News| Tagged , , , |